This is a $10 per share announcement IMHO, if not a 10x announcement.
Significantly de-risks the FTO pillar. Value according to directors is multiples of the billions for the chemotherapeutic applications of Bisantrene (see AGM and interview with Alan Kohler) and surely replication of results increases likelihood of success?
Say 50% of $US10B for FTO? That gives ~$40 share price today.
Ann: Second independent study shows Bisantrene inhibits FTO, page-44
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |